CSANZ Admin News Archive

VALE | Dr David Hunt, MBBS, FRACP, FCSANZ, DDU, FACC

It is with deep regret that we note the passing of Dr David Hunt, MBBS, FRACP, FCSANZ, DDU, FACC, who died at his home in Melbourne on Thursday 11 January 2024.  On behalf of the Cardiac Society Board and members, we would like to extend our sincere sympathies to his family and CSANZ colleagues.

Read in full here 

Image courtesy: Planning retirement from practice – Dr David Hunt discusses his career and retirement from his life long work on Youtube (RACP Channel) Dr Hunt’s own photo found in the CSANZ’s historical record of Cardiology of Australia and New Zealand, section 5.4 on the Royal Melbourne Hospital (contributors Dr David Hunt and Dr Alan Goble).

CSANZ Admin News Archive

Heart, Lung and Circulation | Editor in Chief

Prof Robert Denniss (outgoing Editor in Chief) and A/Prof Salvatore Pepe (new Editor in Chief).

On behalf of the Society we offer our congratulations to A/Prof Salvatore Pepe as the incoming Editor in Chief of the Heart, Lung and Circulation Journal (HLC) for the Cardiac Society of Australia and New Zealand (CSANZ) and the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS). Read more about A/Prof Pepe here. 

We would like to acknowledge and thank Prof A.R. (Robert) Denniss for his extensive service as Editor in Chief of the HLC. Prof Denniss first joined the CSANZ in 1988, served on the CSANZ Board from 2012-2022 as the appointed Editor in Chief of the HLC.

During his tenure, he created insightful initiatives: including the appointment of editorial fellows, a commissioning editor, introduction of prizes for best review and high impact, and establishing a HLC session at the CSANZ ASM in conjunction with the European Heart Journal and other international publications. Also during his time as Editor in Chief, the journal published 132 issues, 17,330 pages, 2,620 manuscripts, 25 scientific meeting abstracts and presented 38 awards.  Read more about Prof Dennis here.

We are grateful for Prof Denniss’ valuable contributions over the past 11+ years as Editor in Chief and CSANZ Board Member.

CSANZ Admin News Archive

Patricia M. Davidson Lecture

The Cardiovascular Nursing Council submitted a proposal for the Board’s consideration to re-name the Cardiovascular Nursing Lecture in honour of Prof Patricia Davidson and it was unanimously approved at the Board meeting on 3 November 2023.

The Cardiovascular Nursing named lecture, presented prior to the Cardiovascular Nursing Prize session at the Annual Scientific Meeting of the Cardiovascular Society of Australia and New Zealand (CSANZ), will now be named the Patricia M. Davidson Lecture, in recognition of Professor Davidson’s considerable contribution to the nursing profession in Australia, internationally and to CSANZ.

Throughout her career, Professor Davidson has been focussed on mentoring the next generation of health professionals and scientists. In 2016, she was the first nurse to receive the Australian Museum Eureka Prize for Outstanding Mentor of Young Researchers. Prof Davidson has received funding from the National Institutes of Health, the National Health & Medical Research Council, and the Australian Research Council. She has received multiple awards in recognition of her contributions to cardiovascular care and nursing. In 2021 she was the recipient of the Consortium of Universities for Global Health (CUGH) Distinguished Leader Award and the 2021 Advance Awards winner in the Education and Research category.

Prof Patricia Davidson was appointed Vice-Chancellor and President of the University of Wollongong in May 2021. Prior to this current role, she was the dean of the Johns Hopkins School of Nursing in Baltimore, USA and a professor in the Bloomberg School of Public Health. Her career has focused on improving the outcomes of individuals with chronic illness and developing policy relevant health interventions. As a global leader in nursing, health care, and advocacy, Prof Davidson’s work focuses on person-centred care delivery and the improvement of cardiovascular health outcomes for women and at risk populations.

Prof Davidson has been instrumental to developing the leading cardiovascular nurse researchers in Australia to improve cardiovascular health of their communities. She is committed to mentoring the next generation of research leaders across many disciplines. 

Through her research career, she has supervised more than 56 doctoral students. She has over 700 publications, a large number are published with students, mentees, clinical collaborators and fellow nurse scientists, many of whom are former students or mentees.

CSANZ Admin News Archive

Patricia M. Davidson Lecture

The Cardiovascular Nursing Council submitted a proposal for the Board’s consideration to re-name the Cardiovascular Nursing Lecture in honour of Prof Patricia Davidson and it was unanimously approved at the Board meeting on 3 November 2023.

The Cardiovascular Nursing named lecture, presented prior to the Cardiovascular Nursing Prize session at the Annual Scientific Meeting of the Cardiovascular Society of Australia and New Zealand (CSANZ), will now be named the Patricia M. Davidson Lecture, in recognition of Professor Davidson’s considerable contribution to the nursing profession in Australia, internationally and to CSANZ.

Throughout her career, Professor Davidson has been focussed on mentoring the next generation of health professionals and scientists. In 2016, she was the first nurse to receive the Australian Museum Eureka Prize for Outstanding Mentor of Young Researchers. Prof Davidson has received funding from the National Institutes of Health, the National Health & Medical Research Council, and the Australian Research Council. She has received multiple awards in recognition of her contributions to cardiovascular care and nursing. In 2021 she was the recipient of the Consortium of Universities for Global Health (CUGH) Distinguished Leader Award and the 2021 Advance Awards winner in the Education and Research category.

Prof Patricia Davidson was appointed Vice-Chancellor and President of the University of Wollongong in May 2021. Prior to this current role, she was the dean of the Johns Hopkins School of Nursing in Baltimore, USA and a professor in the Bloomberg School of Public Health. Her career has focused on improving the outcomes of individuals with chronic illness and developing policy relevant health interventions. As a global leader in nursing, health care, and advocacy, Prof Davidson’s work focuses on person-centred care delivery and the improvement of cardiovascular health outcomes for women and at risk populations.

Prof Davidson has been instrumental to developing the leading cardiovascular nurse researchers in Australia to improve cardiovascular health of their communities. She is committed to mentoring the next generation of research leaders across many disciplines. 

Through her research career, she has supervised more than 56 doctoral students. She has over 700 publications, a large number are published with students, mentees, clinical collaborators and fellow nurse scientists, many of whom are former students or mentees.

CSANZ Admin News Archive

MBS UPDATES: Two New Diagnostic imaging services

Commencing 1 July 2024, two new diagnostic imaging MBS abdominal MRI items will be available for patients with a defined rare inherited condition associated with an increased risk of renal tumours, as well as ongoing assessment of changes over time to an existing renal tumour. This implements a recommendation from the Medical Services Advisory Committee (MSAC):

MSAC – 1702 – Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours

The MBS listing for cardiac MRI for myocarditis associated with mRNA COVID-19 immunisation (Item 63399) has been extended until 31 December 2024. MSAC is currently considering cardiac MRI in the diagnosis of myocarditis more broadly, which is anticipated to be considered in April 2024:

MSAC – 1713 – Cardiac MRI in the diagnosis of myocarditis.

CSANZ Admin News Archive

Heart, Lung and Circulation December Highlights

Here’s a snapshot of some of the most recent Heart, Lung and Circulation Journal articles for December 2023.

Anticoagulation During PCI:  Is It Time for RCTs?

Unfractionated heparin (UFH) has been the preferred anticoagulant in percutaneous coronary intervention (PCI) for over 40 years, say Al-Mukhtar and colleagues. Recently, they surveyed interventional cardiologists in Australia and New Zealand and found that, while this practice is indeed standard, there’s a lot of variation in not only how much (and when) UFH is used in PCI, but also whether (and when) activated clotting time is measured. Al-Mukhtar et al. say their survey results reflect variations in international guidelines and the findings of past studies and meta-analyses. They call for further randomised controlled trials to guide clinical practice and optimise the clinical outcomes of contemporary PCI. https://www.heartlungcirc.org/article/S1443-9506(23)04362-7/fulltext 

Sudden Death in the Young:  Autopsies for Underlying Causes?

One in four cases of young sudden death have more than one potential primary cause of their death identified, according to Paratz and colleagues. In an analysis of 3 years of data from the End Unexplained Cardiac Death (EndUCD) Registry, they determined, among other things, that comprehensive autopsy remains the gold standard investigation in this circumstance, complemented by other data such as, from post-mortem whole-body CT scanning, and biochemical and toxicological assessment. Paratz et al. say identifying all contributors to a sudden death is important, especially as diagnoses may carry important implications for surviving family members.  https://www.heartlungcirc.org/article/S1443-9506(23)04398-6/fulltext

After SCAD: What Could Standard Care in Recovery Look Like?

Not only physical but also emotional recovery is important for patients after spontaneous coronary artery dissection. So say Turner and colleagues, who conducted a comprehensive literature review that identified, and then examined the findings of, five studies involving 447 patients after SCAD. They suggest that the ideal recovery program would reflect the patients’ preference for tailored cardiac rehabilitation and web-based resources, both specifically designed for SCAD. For example, with respect to emotional recovery, cognitive behavioural therapy-based groups and online peer support have been shown to benefit patients with spontaneous coronary artery dissection (SCAD) and could be integrated into standard care.  https://www.heartlungcirc.org/article/S1443-9506(23)04367-6/fulltext

These highlights and more are available online now in the December 2023 edition of Heart, Lung and Circulation.

Compiled by Dr Ann Gregory, Commissioning Editor, Heart, Lung and Circulation.  ([email protected])

CSANZ Admin News Archive

Empagliflozin is now on the PBS – Read more here including accessing the Online PBS Authorities system

Empagliflozin (Jardiance®) (10 mg tablet) is now listed on the PBS for the treatment of chronic heart failure.

Chronic heart failure

Empagliflozin (Jardiance®) (10 mg tablet) is now listed on the PBS for the treatment of chronic heart failure. Prescriptions for treatment are Authority Required (STREAMLINED).

Download the Frequently Asked Questions (FAQs) relating to access and including the use of the Online PBS Authorities system  

For more information about the Online PBS Authorities system visit www.servicesaustralia.gov.au/hppbsauthorities

CSANZ Admin News Archive

R T Hall Prize

We are delighted to announce the 2023 R T Hall Prize is awarded to Prof Gemma Figtree AM. The RT Hall Prize is the most prestigious research award of CSANZ and recognises the achievements of senior and established investigators.

Over the last 10 years Prof Figtree has led an expanding international team addressing the mechanisms and unmet needs regarding clinical pathways for patients who develop coronary artery disease and myocardial infarction despite no standard modifiable risk factors (SMuRFs).

She is the National Scientific Lead of the large global clinical trial AEGIS II and was appointed to the adjudication panel, co-leading the heart failure analyses and publications for the highly cited CANVAS program demonstrating of benefits of SGLT2 inhibition in diabetics.

Using validated pre-clinical models, she has made seminal contributions that have provided unique insights into the mechanisms of cardiovascular disease susceptibility.

An impressive line up!

Captured at this year’s CSANZ ASM was an impressive line up of previous R T Hall Prize winners. Pictured together here, at the 2023 CSANZ ASM President’s Welcome on Thursday evening – an “RT Hall Prize Hall of Fame”. 

View the full list R T Hall Prize winners below from 1965 to date. 

RT Hall Prize Winners

(from left to right): Prof Paul Nestel (awarded in 1965, the first RT Hall Prize recipient), guest with Prof Gerald Watts (2022), Prof Phil Aylward (1984) and Prof Stephen Nicholls (2018). 

 

CSANZ Admin News Archive

LIVE PANEL | Managing CVD with Obesity | Outcomes from the AHA Scientific Sessions 2023

ADS will host an exciting virtual event.
Join the experts, including Prof John Atherton, A/Prof Sarah Glastras, A/Prof Samantha Hocking, Prof Stephen Nicholls and Prof Sophia Zoungas for a Live Panel Discussion on Monday 13 November 2023 from 7.00pm – 8.00pm (AEDT). 

Discussion will cover the outcomes of the 2023 AHA Scientific Sessions in relation to managing cardiovascular disease in people living with obesity, plus a review of the trial results presented at the AHA Meeting.   Download the flyer for full details.  Register here for the Live Discussion 

CSANZ Admin News Archive

LIVE PANEL | Managing CVD with Obesity | Outcomes from the AHA Scientific Sessions 2023

ADS will host an exciting virtual event. Join the experts, including Prof John Atherton, A/Prof Sarah Glastras, A/Prof Samantha Hocking, Prof Stephen Nicholls and Prof Sophia Zoungas for a Live Panel Discussion on Monday 13 November 2023 from 7.00pm – 8.00pm (AEDT). 

Discussion will cover the outcomes of the 2023 AHA Scientific Sessions in relation to managing cardiovascular disease in people living with obesity, plus a review of the trial results presented at the AHA Meeting.   Download the flyer for full details here 

Posts navigation

1 2 3 4 5 6 7 8 … 18